Hematology/Oncology

Top Story

Mortality risk likely to be higher among uninsured patients

June 27, 2017

With the Congressional Budget Office report indicating that 22 million Americans will lose insurance coverage by 2026 under the Senate’s proposed Better Care Reconciliation Act, a recent study published in Annals of Internal Medicine shows that a lack of insurance is associated with increased mortality.

In this study, Steffie Woolhandler, MD, MPH, and David U. Himmelstein, MD, from City University of New York School of Urban Public Health at Hunter College and Harvard Medical School, summarized the current evidence relating to the connection between insurance and mortality. Currently, approximately 28 million people in the United States are uninsured, and the repeal of the Affordable Care Act (ACA) will cause millions more to loss coverage. In the face of these legislative changes, some policy leaders are advocating for a single-payer national health insurance system that would provide every American with insurance coverage.

In the Journals Plus

Hypofractionated radiotherapy may improve glottic cancer survival

June 27, 2017
Hypofractionated radiotherapy improved survival in patients with early-stage glottic cancer compared with conventionally fractionated radiotherapy, according to a study…
FDA News

FDA releases plan to expedite, promote generic drug development

June 27, 2017
As part of its effort to increase competition in the prescription drug market, the FDA released a list of drugs that are off-patent and off-exclusivity without approved…

Armed with CBO report, AAFP sharply critical of Senate health care bill

June 27, 2017
AAFP has unleashed a new round of criticism in the wake of the Congressional Budget Office releasing an analysis of the Senate health care bill known as the Better Care…
In the Journals Plus

Biomarkers may guide personalized therapy for castration-resistant prostate cancer

June 27, 2017
Assessment of androgen receptor gene status in plasma DNA identified patients with castration-resistant prostate cancer with worse outcomes to standard therapy…
More News Headlines »
CME

Polycythemia Vera: Aligning Real World Practices With Current Best Practices

This activity is supported by an independent educational grant from Incyte Corporation.

Ruben A. Mesa, MD, provides practical insights into treating polycythemia vera in this video series. In addition to…
More »
Video
Meeting News

VIDEO: Immunotherapy agent induces response in prostate cancer

June 20, 2017
More »
Featured

CNE CME

The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement